Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Osimertinib reduces risk of metastasis, CNS progression in NSCLC
13 Dec 2024
bởiStephen Padilla
Treatment with osimertinib following chemoradiotherapy (CRT) helps lower the risk of distant metastases and central nervous system (CNS) disease progression in patients with unresectable stage III epidermal growth factor receptor-mutated (EGFRm) nonsmall cell lung cancer (NSCLC), results of the phase III LAURA study have shown.
Osimertinib reduces risk of metastasis, CNS progression in NSCLC
13 Dec 2024
Ribociclib plus radiotherapy feasible in metastatic breast cancer
13 Dec 2024
The addition of CDK4/6 inhibitor ribociclib to palliative radiotherapy is relatively safe in patients with metastatic breast cancer, reports a study.
Ribociclib plus radiotherapy feasible in metastatic breast cancer
13 Dec 2024
Metformin improves responses to chemotherapy in nondiabetic breast cancer
11 Dec 2024
Use of metformin in nondiabetic breast cancer patients improves their clinical and pathological response to neoadjuvant AC-T chemotherapy, reveals a recent study.
